Whilereactivating the transcription of the PTEN protein can be achieved via CRISPR technology, we believe that EVs may have therapeutic implications by engineering vesicles that mimic naturally occurring EVs containing PTEN or lncRNA/PTENP1, which restore PTEN expression in target cells and suppress tumor growth. The gene discussed is PTENP1; the disease is neoplasm.